NCT04887506 TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT04876651 The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only Status TERMINATED Phase PHASE3
NCT04846478 Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04787744 Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT04786847 177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study Status COMPLETED Phase PHASE1
NCT04746300 imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS Status UNKNOWN Phase N/A
NCT04726033 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) Status COMPLETED Phase EARLY_PHASE1
NCT04709276 A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04662580 ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04545697 mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer Status COMPLETED Phase NA
NCT04533958 Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy Status COMPLETED Phase NA
NCT04528199 [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer Status TERMINATED Phase PHASE1
NCT04478279 A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04446117 Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Status COMPLETED Phase PHASE2
NCT04332744 Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) Status COMPLETED Phase PHASE2
NCT04330716 Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers Status COMPLETED Phase NA
NCT04262154 Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04220983 PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer Status COMPLETED Phase NA